InvestorsHub Logo
Followers 0
Posts 157
Boards Moderated 0
Alias Born 04/28/2017

Re: AntonChigurh post# 2640

Friday, 07/28/2017 10:07:16 PM

Friday, July 28, 2017 10:07:16 PM

Post# of 6315
I've read that Cesamet claimed to have ~90% market share in Canada as well.

I'm sure it's more than $50mm, but the market for a suppository formulation wouldn't be as large, and if they in-license the royalty will be low.